Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies
Clinical trial NCT06993025 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06993025
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-25
- Primary completion
- 2026-04-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.